23 November 2014
: Case report
Spontaneous Hemarthrosis Following Fibrinolytic Therapy for Acute Myocardial Infarction: A Case Report and Literature Review
Unusual clinical course, Diagnostic / therapeutic accidents, Management of emergency care, Adverse events of drug therapy
Mahmoud M. RamadanABDEF, Iqbal S. KhanB, Ousama MahdiDDOI: 10.12659/AJCR.892138
Am J Case Rep 2014; 15:514-517
Abstract
BACKGROUND: Despite the widespread use of fibrinolytic therapy and the numerous reports on its bleeding complications, spontaneous hemarthrosis following fibrinolytic therapy is quite rare.
CASE REPORT: We describe in this report a patient with no previous history of articular disease who developed a spontaneous right knee bloody effusion following fibrinolytic therapy using rt-PA for acute ST-elevation myocardial infarction. Furthermore, we provide a review of all cases of spontaneous hemarthrosis documented so far in the literature.
CONCLUSIONS: Several pre-existing joint diseases may predispose to hemarthrosis following fibrinolytic therapy, even in patients who deny previous or current articular disorders. Therefore, hemorrhage should be considered in the differential diagnosis of mono-arthritis following fibrinolytic therapy for STEMI.
Keywords: Fibrinolytic Agents - therapeutic use, Hemarthrosis - diagnosis, Myocardial Infarction - drug therapy, Thrombolytic Therapy - adverse effects, Tissue Plasminogen Activator - therapeutic use
1016 10
In Press
01 Dec 2023 : Case report
Am J Case Rep In Press; DOI:
01 Dec 2023 : Case report
Am J Case Rep In Press; DOI:
01 Dec 2023 : Case report
Am J Case Rep In Press; DOI:
30 Nov 2023 : Case report
Am J Case Rep In Press; DOI:
Most Viewed Current Articles
06 Dec 2021 : Case report
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
07 Dec 2021 : Case report
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
19 Jul 2022 : Case report
DOI :10.12659/AJCR.936128
Am J Case Rep 2022; 23:e936128
13 Jul 2022 : Case report
DOI :10.12659/AJCR.936441
Am J Case Rep 2022; 23:e936441